Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The chronic diseases such as obesity, type 2 diabetes, coronary heart disease, dyslipidemia, and hypertension is alarmingly
increasing rapidly. Obesity predisposes to many diseases. There are genetic and non genetic factors reported to be associated
with obesity. Screening of pre-obesity individuals may be helpful in early management and prevention of other obesity associated
diseases. In this study, the WHO Asia Pacific Guidelines 2000 was followed to classify the subjects on the basis of their BMI. A total
of 300 Type 2 diabetes mellitus individuals were included. Pregnant women and subjects suffering from thyroid problems were
excluded from the study. Demographic characteristics were analysed. Molecular analysis of the LEPR gene polymorphism was carried
out by Polymerase Chain Reaction-Restricted Fragment Length Polymorphism (PCR-RFLP). 14.62% were found to be pre-obese
(2325) and 16.7% were Morbid Obese (BMI>30). 58.8%. The heterozygous and homozygous variants
were associated with BMI. The pre-obese individuals showed 78.1% heterozygous and 21.8% homozygous variants as compared to the
obese individuals (66% and 34% respectively). This study reports the association of LEPR polymorphisms on pre-obesity and Type 2
diabetes mellitus in this ethnic population. Thus the prevalence of high risk group individuals could be identified and counseled, and
medical intervention carried out for an early management.